期刊文献+

中药健脾益肺消积汤维持治疗中晚期非小细胞肺癌临床疗效观察

Chinese medicine tonifying the lung and eliminating product soup in the maintenance treatment of advanced non small cell lung cancer clinical efficacy
下载PDF
导出
摘要 目的:探讨中药健脾益肺消积汤在中晚期非小细胞肺癌患者维持治疗中的作用。方法:48名中晚期非小细胞肺癌患者随机分为两组,治疗组(口服健脾益肺消积汤)26例和对照组(口服复方斑螫胶囊)22例,对患者进行维持治疗,评价患者生存质量和生存期。结果:治疗组QLQ-C30评分与对照组有显著差异(P〈0.05),治疗组和对照组6个月生存率无显著差异,而1年生存率和18个月生存率有显著性差异,(P〈0.05)。结论:中药健脾益肺消积汤与复方斑螫胶囊相比更能延长晚期.改善生活质量。 Objective.. To investigate the TCM spleen Yifei Xiaoji soup maintain a role in the treatment. Method.. 48 advanced non-small cell lung cancer patients were randomly divided into two groups, the treatment group (oral spleen Yifei consumer product in patients with advanced non-small cell lung cance r22 cases of soup) in 26 cases and the control group (oral compound cantharidin capsule) ,maintenance treatment of patients,and the evaluation of quality of life and survival of patients. Result: QLQ--C30 score of the treatment group and the control group were significantly different (P〈0.05), 6-month survival rate of the treatment group and the control group no significant difference in 1-year survival rate and survival rate of 18 months, a significant difference, (P〈0.05). Conclusion; TCM spleen Yifei Xiaoji soup with compound cantharidin capsule compared to more to extend late. Improve the quality of life.
作者 曾灵芝
出处 《河南中医》 2013年第B10期1-2,共2页 Henan Traditional Chinese Medicine
关键词 非小细胞肺癌 健脾益肺 消积汤 维持治疗 non-small cell lung cancer, Spleen Yifei, Xiaoji soup, maintenance treatment
  • 相关文献

参考文献8

二级参考文献53

  • 1翟玉珍,包剑刚.中药三期疗法抗肿瘤治疗思路[J].河北医药,2004,26(11):898-899. 被引量:5
  • 2李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 3张庆民,龚惠明主编.抗肿瘤中药的临床应用.第1版.北京:人民卫生出版社,1998.407.
  • 4Smith KL. Mechanism of muscle protein degradation in cancer cachexia[ J]. Br J Cancer, 1993,68 (2) :314 - 318.
  • 5Zhu Peisen. Results of Kanglaite(KLT) containing regimens in recurrent and/or metastatic advanced lung cancer [ J ]. J US Chin Med,1998,4(2) : 4-6.
  • 6李同度,刘爱国,秦叔逵,等.康莱特注射液控制癌痛及提高晚期癌症患者生存质量的临床研究[C].世界中西医结合大会论文摘要集,1997.
  • 7[1]Central European Cooperative Oncology Group (CECOG); Advisory Committee on Collaboration with Industry in Medical Education of the European School of Oncology (ESO); Vienna Medical Association, Consensus on medical treatment of non-small cell lung cancer. Lung Cancer,2002,38(Suppl 3)∶S3-S7.
  • 8[3]Abeloff MD, Armitage JO, Lichter AS, et al eds. Clinical Oncology 2 ed. Singapore: HARCOURT ASIA,1999.1423-1426.
  • 9[4]Hansen HH eds. Textbook of lung cancer. 1ed. London: Martin Dunitz,2000.230-233.
  • 10[5]Fossella FV, DeVore R, Kerr RN, et al. Randomized phase Ⅲ trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. J Clin Oncol,2000,18(12)∶2354-2362.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部